What is Thermo Fisher Scientific Inc.'s (TMO) StockRank?

MoatMap's StockRank for Thermo Fisher Scientific Inc. (TMO) is 59/100, with a Hold signal. This is a composite score combining Quality (55), Value (32), and Momentum (66) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Thermo Fisher Scientific Inc. have an economic moat?

Thermo Fisher Scientific Inc. (TMO) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Thermo Fisher Scientific Inc. a buy, hold, or sell?

MoatMap's current signal for Thermo Fisher Scientific Inc. (TMO) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Thermo Fisher Scientific Inc. in?

Thermo Fisher Scientific Inc. (TMO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TMO

HoldPremium Grower

Thermo Fisher Scientific Inc. · Healthcare · United States · $230.0B · Avg Vol: $1.0B/d

StockRank

Get insider-trade alerts

P/E (TTM)

33.1x

ROE

13.5%

D/E

0.8x

Dividend %

0.3%

COMPANY DESCRIPTION

Thermo Fisher Scientific Inc. is the world leader in serving science, providing analytical instruments, laboratory equipment, reagents, consumables, and services for research, clinical diagnostics, and industrial applications. Its extensive product portfolio, integrated solutions, and high switching costs create a significant competitive moat. The company maintains a market-leading position across diverse scientific disciplines and geographies, making it an essential partner for global R&D and healthcare advancement.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	44.9B	42.9B	42.9B	44.6B	-0.3%	46.3B	47.9B	50.3B	6.3%
EPS	17.75	15.52	16.58	17.77	0.0%	18.55	19.53	21.39	9.7%
Shares	390.5M	386.6M	380.8M	376.2M	-3.7%	369.7M	—	—	—
Debt	34.5B	34.9B	31.3B	39.4B	4.5%	42.5B	—	—	—
Equity	44.0B	46.7B	49.6B	53.4B	6.7%	—	—	—	—
Op CF	9.2B	8.4B	8.7B	7.8B	-5.1%	9.0B	—	—	—
Inv CF	-2.2B	-5.1B	-5.8B	-4.0B	—	—	—	—	—
Fin CF	-2.8B	-3.6B	-6.8B	1.8B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+4.6%

SMA 50SMA 200

$603.18

RSI (14)

34.8

52W High

$647.00

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

9.2%68.4

ROE

13.5%79.3

GP/Assets

17.2%38.8

Op. Margin

18.8%81.2

FCF/Assets

5.0%70.1

Piotroski

549.1

Int. Cover

6.2x54.5

D/E Ratio

0.81x17.8

Current Ratio

1.55x27.9

Value

P/E (TTM)

33.1x36.5

EV/EBITDA

22.6x29.8

P/FCF

41.7x35.3

P/B

4.3x33.8

P/S

4.9x42.3

Div Yield

0.3%8.1

Momentum

52W High %

93%92.5

RS 6M

9%74.3

SMA 50/200

1.08x71.9

EPS Rev 4W

+0.1%40.9

EPS Rev 12W

+1.0%51.1

EPS Improve

+48%53.7

Q Growth

7%45.1

FUNDAMENTALS

Market Cap

$230.0B

P/E (Forward)

22.3x

Gross Margin

41.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMO are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TMO	Thermo Fisher Scientific Inc.(you)	$230.0B	59	Hold
DHR	Danaher Corporation	$151.9B	59	Hold
LONN.SW	Lonza Group AG	$50.4B	56	Hold
IDXX	IDEXX Laboratories, Inc.	$43.7B	58	Hold
NTRA	Natera, Inc.	$47.0B	56	Hold
WAT	Waters Corporation	$40.7B	62	Hold
MTD	Mettler-Toledo International Inc.	$28.0B	60	Hold
IQV	IQVIA Holdings Inc.	$43.1B	73	Buy
A	Agilent Technologies, Inc.	$43.4B	75	Buy
2359.HK	WuXi AppTec Co., Ltd.	$75.0B	92	Strong Buy

Peer medians: ROE 2.9% · P/E 24.4x · Gross margin 52.5%

Thermo Fisher Scientific Inc. (TMO): Stock Score Summary

Thermo Fisher Scientific Inc. (TMO) has a MoatMap StockRank of 59/100 based on Quality (55/100), Value (32/100), and Momentum (66/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$603.18
Market Cap	$230.0B
P/E (TTM)	33.09
P/E (Forward)	22.30
Price/Book	4.31
Return on Equity	13.5%
Return on Invested Capital	9.2%
Debt/Equity	0.81x
Gross Margin	41.0%
Operating Margin	18.8%
Revenue Growth	10.5%
Dividend Yield	0.3%
Free Cash Flow	$5.5B

Thermo Fisher Scientific Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Thermo Fisher Scientific Inc.’s (TMO) StockRank?: MoatMap’s StockRank for Thermo Fisher Scientific Inc. (TMO) is 59/100, with a Hold signal. It is a composite of Quality (55), Value (32), and Momentum (66) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Thermo Fisher Scientific Inc. have an economic moat?: Thermo Fisher Scientific Inc. (TMO) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Thermo Fisher Scientific Inc. a buy, hold, or sell?: MoatMap’s current signal for Thermo Fisher Scientific Inc. (TMO) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Thermo Fisher Scientific Inc. in?: Thermo Fisher Scientific Inc. (TMO) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).